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Abstract 
In February 2016, the Company of Biologists hosted an intimate gathering of leading 
international researchers at the forefront of experimental cardiovascular regeneration, with its 
emphasis on ‘Transdifferentiation and Tissue Plasticity in Cardiovascular Rejuvenation’.  As I 
review here, participants at the workshop revealed how understanding cardiac growth and 
lineage decisions at their most fundamental level has transformed the strategies in hand that 
presently energize the prospects for human heart repair. 
 
Introduction 
The first organ to be fashioned during embryogenesis - the heart - is the organ that 
contributes most, worldwide, to death, disability and healthcare system costs (Roth et al., 2015). 
This daunting global burden is due most often to coronary artery obstruction, but is also 
compounded by inbuilt biological limitations that constrain the renewal of human 
cardiomyocytes, preventing effective self-repair.  No approved therapy targets cardiac regrowth, 
making urgent the case to explore regenerative medicine approaches. The publishers of 
Development recently hosted a workshop entitled “Transdifferentiation and Tissue Plasticity in 
Cardiovascular Rejuvenation,” which was organized by Brian Black (University of California, 
San Francisco, USA) and Jim Martin (Baylor College of Medicine, Houston, USA), aiming to 
provide developmental perspectives on cardiac regeneration and repair. Rather than dwell on 
past controversies, the participants shared a prudent perspective that no therapy now in human 
trials was likely to be optimal, and that a panoply of development-led remedies is yet to be 
unleashed. 
Cardiac progenitors and stem cells 
Specification of the cardiac lineage during gastrulation in mouse embryos was 
addressed by Elizabeth Robertson (University of Oxford, UK).   The Nodal, BMP, and Wnt3 
pathways are essential to induce nascent mesoderm in the primitive streak (Sampath and 
Robertson, 2016). A key target of Nodal and its receptor-activated effector, phosphorylated 
Smad2/3, is the T-box gene Eomesodermin (Eomes), and the recent fate-mapping of Eomes-
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derived cells (Costello et al., 2011) suggests that Eomes is crucial for the emergence of both 
definitive endoderm and cardiovascular progenitors. Robertson described how one transcription 
factor activated directly by Eomes – Lhx – is required for normal midline and head structure 
morphogenesis, yet dispensable for the heart (Nowotschin et al., 2013; Costello et al., 2015). By 
contrast, Mesp1 and Mesp2 are direct Eomes targets that are crucial for cardiovascular 
development.  She further showed that Eomes along with Tbx6 binds an essential early 
mesodermal enhancer shared by Mesp1 and Mesp2, and deletion of this element prevents 
Mesp1/2 activation, EMT, and induction of the cardiovascular progenitors. 
Cardiovascular origins were also discussed by Christian Mosimann (University of Zurich, 
Switzerland). In vertebrates such as zebrafish, lateral plate mesoderm (LPM)-derived cell types 
include not only the heart, but also blood vessels, blood, kidney and pectoral fins. Mosimann 
described how a 6.5 kb fragment of the zebrafish draculin (drl) upstream region initially labels all 
LPM derivatives but becomes restricted just to cardiovascular and hematopoietic lineages and, 
later still in the heart, just to first heart field (FHF) descendants (Mosimann et al., 2015).  Further 
dissection of the drl locus revealed a pan-LPM enhancer plus anterior and posterior LPM 
enhancers, while drl reporter zebrafish showed that regulators of cardiac septation control the 
heart fields’ contributions, with loss of pitx2ab diminishing the FHF and loss of tbx5 expanding it 
(Mosimann et al., 2015). Using panoramic lightsheet microscopy of drl reporters, combined with 
sox17-based endoderm labeling, the stepwise specification of the LPM from mesendoderm 
could be documented. Intriguingly, the drl pan-LPM enhancer drives reporter activity in different 
model organisms, suggesting that a conserved upstream program defines the initial LPM and 
sets the stage for subsequent cardiovascular development.   
Turning to cardiac progenitors in adult hearts, Michael Schneider (Imperial College 
London, UK) investigated dormant cardiac progenitor/stem cells identified in adult mice initially 
on the basis of stem cell antigen-1 (Sca1) expression (Oh et al., 2003) and refined according to 
their side population (SP) dye-efflux phenotype (Matsuzaki et al., 2004) and PDGFRα 
expression, features that pinpoint the clonogenic cardiogenic Sca1+ cell (Noseda et al., 2015a; 
Noseda et al., 2015b). The cloning efficiency of fresh PDGFRα+ SP cells in physiological O2 is a 
noteworthy 30%. Single-cell progeny show multi-lineage potential after cardiac grafting, with 
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well-organized sarcomeres and incorporation into blood vessels at 12 weeks. However, durable 
engraftment is rare, implicating early paracrine effects as most credible for the large benefits 
observed (reduced scar size, improved pump function, reduced dilatation). Schneider further 
described how a microgroove-patterned substrate, investigated in collaboration with Molly 
Stevens (Imperial College London, UK), enhances the programming of adult cardiac stem cells 
toward a cardiomyocyte fate (Morez et al., 2015). These results highlight the impact of purely 
physical signals on cardiac stem cell function.  
Richard Harvey  (Victor Chang Cardiac Research Institute, Sydney, Australia) discussed 
cardiac mesenchymal/stromal cells that resemble the archetypal mesenchymal stem cell in 
bone marrow, using the colony-forming assay pioneered almost 50 years ago (Friedenstein et 
al., 1970). The resulting cardiac Colony-Forming Unit-Fibroblast (cCFU-F) (Chong et al., 2011) 
has broad mesodermal plasticity and even tri-germ-layer potential in culture. Harvey showed 
that the starting Sca1+ PDGRα+ CD31- cells (S+P+) from which the colonies arise are 
perivascular, but based on their anatomical position are not pericytes. Flow cytometry with 
pyronin Y, a marker of RNA content, demonstrated that many of these cells are quiescent in 
healthy hearts but activated following cardiac injury. Parabiosis of old mice with young mice 
rescued the growth properties of S+P+ cells from older hearts. Encouraging evidence that 
endogenous S+P+ cells may be a rational target for therapeutic modulation was their 
enhancement by PDGF-AB infusion, accompanied by reduced scar size and improved cardiac 
function. 
Together these studies of cardiac myogenesis in the embryo and later cardiac 
progenitors reveal the complexities of patterning the Eomes-specified mesoderm, but also the 
importance of secretory signals both to and from the cardiac stem cell. 
 
Lymphangiogenesis in the cardiovascular system and beyond 
Paul Riley (University of Oxford, UK) discussed the development of cardiac lymphatic 
vessels. Historically, two views have contended: that lymphatics arise wholly by budding off from 
veins, or instead arise from mesenchymal cells (Semo, et al. 2016). Riley described how cardiac 
lymphatics, marked by Vegfr3 and Prox1, develop only in part from the common cardinal vein, a 
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portion being Tie2-negative (not venous-derived). Further fate-mapping excludes the pro-
epicardial organ, cardiac mesoderm and cardiac neural crest as the source of these 
unexplained lymphatic endothelial cells, pointing instead to haemogenic endothelium (Klotz et 
al., 2015). Cardiac injury induces neo-lymphangiogenesis, inducing the developmental 
programme (Vegfr3, Lyve1, Prox1) and extensive lymphangiogenic sprouting after myocardial 
infarction. This neo-lymphangiogenesis can be augmented by recombinant VEGF-C during 
cardiac self-repair, reducing infarct size and improving ventricular performance (Klotz et al., 
2015).   
Karina Yaniv (Weizmann Institute, Rehovot, Israel) likewise studied lymphangiogenesis. 
Fate-mapping with the photoconvertible protein Kaede expressed in zebrafish endothelial cells 
showed that more than 90% of lymphatic progenitors arise from the ventral posterior cardinal 
vein (PCV), in close contact with endoderm (Nicenboim et al., 2015).  However, ventral PCV 
cells are heterogeneous, also generating arteries and veins, indicating they are angioblasts, not 
venous cells.  Imaging the cardiac lymphatics with fli:egfp in addition to lyve1:dsred and 
prox1:RFP revealed that the vessels sprout from the outflow tract and are indeed 
heterogeneous in origin. PCV-specialized angioblasts also provide a common origin for all 
vessels of the subintestinal plexus – the vessels that vascularize the gut, liver and pancreas 
(Hen et al., 2015).     
Driving cardiomyocyte proliferation in the embryo, neonate, and adult  
In zebrafish (Kikuchi and Poss, 2012) and newborn mice (Porrello and Olson, 2014), 
new cardiomyocytes are created after injury and culminate in scarless healing via the 
proliferation of pre-existing myocytes. Ken Poss (Duke University, Durham, USA) described his 
group’s efforts to find regulatory elements that control such regeneration in zebrafish. A 
transcriptomic analysis comparing heart and fin regeneration identified hundreds of genes in 
common, from which some of the most highly induced genes during regeneration were 
exploited to identify DNA regions with areas of chromatin that open during heart regeneration. 
 Poss described ongoing work to examine whether elements identified from these analyses 
could drive the expression of reporter genes or mitogens after injury as a potential means to 
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modify regenerative capacity. 
Also using zebrafish, Nadia Mercader (University of Bern, Switzerland) examined the 
interplay between fibrosis and regeneration during heart repair. Fate-mapping and genetic 
ablations were used to study the contribution of different myocytes to repopulating the injured 
heart, as well as their requirement for extracellular matrix components during myocyte 
proliferation. In contrast, Juliane Münch (Centro Nacional de Investigaciones Cardiovasculares, 
Madrid, Spain) followed the endocardium during zebrafish heart regeneration, distinguishing a 
pathway that promotes endocardial organization after injury and helps terminate inflammation.   
Interactions between endocardial and myocardial cells were highlighted by Didier 
Stainier (Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany), who 
presented elegant studies of trabeculation – the inward growth of cardiac muscle from the outer 
compact layer. Using LIFEACT:GFP to label filamentous actin, Stainier demonstrated that 
trabeculation in zebrafish mostly occurs by delamination and not via oriented cell division (Liu et 
al., 2010). Trabeculae fail to form in zebrafish lacking erbb2, which encodes a Neuregulin 
receptor, and transplanted erbb2 mutant cells fail to incorporate into wild-type trabeculae. The 
trabeculation defect is recapitulated in mutants lacking a specific Neuregulin ligand, which is 
expressed with strikingly periodic expression near the delaminating cells. Also impacting on 
cardiomyocyte development are flow-responsive genes described to be expressed in 
endocardial cells: in zebrafish mutants for some of these genes, cardiomyocytes are aberrantly 
extruded to the abluminal side, further illustrating the complex signaling between endocardial 
and myocardial cells. 
Eldad Tzahor (Weizmann Institute of Science, Rehovot, Israel) also focused on the 
Neuregulin/ErbB2 pathway (D'Uva et al., 2015), as well as features of the cardiomyocyte 
extracellular microenvironment (Yahalom-Ronen et al., 2015). Levels of ErbB2 fall sharply in 
mouse myocardium in the first week after birth, suggesting its loss might mediate the post-natal 
loss of proliferative capacity. Indeed, Tzahor showed that the cardiomyocyte-specific deletion of 
Erbb2 provokes a hypoplastic heart; conversely, even when induced in young adults, “Tet-Off” 
transgenic expression of activated Erbb2 drives myocyte cycling, mitosis and cytokinesis, 
enhancing regenerative growth and function (D'Uva et al., 2015). Intriguingly, the team identified 
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a component of the P1 (but not P7) matrix that promotes cardiomyocyte proliferation. Using 
mass spectrometry, they identified the proteoglycan Agrin and showed that it is essential for 
myocyte proliferation and neonatal heart repair, and sufficient to boost cardiac regeneration in 
juvenile and adult infarct models.       
The role of the Hippo pathway in regulating cardiomyocyte proliferation was discussed 
by James Martin (Baylor College of Medicine, Houston, USA). The scaffold protein, Salvador 
(Salv), is essential for normal Hippo signaling, and Martin discussed how its deletion in the 
developing mouse heart unleashes cardiomyocyte proliferation (Heallen et al., 2011). 
Analogously, its deletion in the adult heart with tamoxifen-dependent Cre enables adult 
myocytes to proliferate robustly and execute effective heart repair (Heallen et al., 2013). ChIP-
Seq and expression profiling of Hippo-deficient hearts showed that the genes targeted by Yap, 
the Hippo pathway transcriptional co-activator, encode cell cycle components, as expected, but 
also notably proteins for actin polymerization and its linkage to the extracellular matrix 
(Morikawa et al., 2015). Strikingly, Hippo-deficient myocytes extend unique sarcomere-filled 
protrusions and are highly invasive in vitro. Hippo-deficient hearts also show a number of fetal 
characteristics that appear to be important for Yap-mediated regenerative potential. Any future 
treatment strategy will thus likely need to finely calibrate Hippo signaling levels. 
Ahmed Mahmoud (Harvard Medical School, Boston, USA) explored the phenomenon 
that cardiomyocyte proliferation after injury depends on nerve activity. Zebrafish were subjected 
to apical cardiac resection and treated with pharmacological blockers (Mahmoud et al., 2015).  
Whereas the beta-adrenergic antagonist propranolol had no effect, cardiomyocyte proliferation 
was blocked by cholinergic inhibitors or genetic reduction of cardiac innervation (cardiomyocyte-
targeted expression of semaphorin3aa). Recapitulating this phenotype in neonatal mice, 
cardiomyocyte proliferation was impaired not only by atropine but also by surgical denervation, 
which caused the dysregulation of diverse genes for immune responses and wound healing, 
potentially linking this neural pathway to inflammatory mechanisms for neonatal mammalian 
heart repair (Aurora et al., 2014). Serum from neonatal mice but not adult mice also had a 
mitotic impact, suggesting systemic contributions from circulating factors.   In this context, 
Andrea Mattiotti (University of Amsterdam, Netherlands) noted that epicardial patches seeded 
with recombinant Fstl1 were recently reported to drive cardiomyocyte cycling, suppress fibrosis, 
and improve cardiac pump function (Wei et al., 2015). Given that the germline deletion of Fstl1 
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is lethal at birth (Sylva et al., 2011) while cardiomyocyte-restricted deletion is lethal at 20-40 
days, Mattiotti and colleagues are generating conditional, knockouts to test if endogenous Fstl1 
is required during heart repair.     
Organ regeneration can also involve the dedifferentiation of mature cells, as highlighted 
by Guo Huang (University of California, San Francisco, USA). Epicardial enhancers and the 
transcription factors that promote the reversion to epicardial progenitor cells have previously 
been mapped (Huang et al., 2012). A functional genomics screen is now underway to promote 
adult mouse cardiomyocyte proliferation, based on viral delivery of the top 50 genes whose 
postnatal expression is down-regulated more severely in cardiomyocytes than in epicardial 
cells.  Indeed, Huang reported that, in long-term cultured adult cells, pooled viruses induce EdU 
labeling in more than 25% of the myocytes, with serial imaging confirming myocyte division. In a 
chemical biology approach (in collaboration with Ralph Marcucio) to enhance regeneration in 
mice (cf. (Choi et al., 2013)), an unexpected but encouraging result is the regrowth of digits after 
their amputation for the purpose of identification. 
 
Materials science and tissue engineering approaches to cardiovascular repair 
Engineering myocardium in vitro, via the creation of tissue patches, was discussed by 
Nenad Bursac (Duke University, Durham, USA) (Zhang et al., 2013; Bian et al., 2014; Jackman 
et al., 2015). Embedding cardiomyocytes from hiPSCs in hydrogel, polymerized in a nylon 
frame, allowed the formation of 60 μm thick tissue patches that exhibit features of maturation. 
These patches become vascularized spontaneously after grafting to mice and can be scaled up 
in size. A limitation that remains is the lack of electrical integration between patch and heart, 
potentially due to scarring and lack of myocyte migration. An intriguing approach to overcome 
this barrier is to engineer cardiac fibroblasts that bridge electrical conduction between patch and 
heart cardiomyocytes. 
Molly Stevens (Imperial College London, UK) gave an overview of her approaches to 
enhance regenerative medicine through materials science, for example via the use of 
conductive polymers to influence arrhythmia inducibility, sutureless bioadhesion, and via the 
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micropatterning of biomaterials to better mimic the anisotropy of the heart. Nano-analytical 
electron microscopy is also being applied to gain insights into cardiovascular tissue calcification 
(Bertazzo et al., 2013; Autefage et al., 2015) while porous silicon nanoneedles have been 
devised for sensing intracellular pH changes and enzyme activities, and for delivering drugs, 
nanoparticles and nucleic acids (Chiappini et al., 2015a; Chiappini et al., 2015b).  
Filippo Perbellini (Imperial College London, UK) discussed cardiac tissue engineering 
from a physiologist’s perspective.  When using pluripotent cell derivatives, chamber identity 
must be matched to the electrophysiological properties of the host milieu. However, essential 
features like action potential morphology, calcium extrusion and calcium content in 
sarcoplastmic reticulum are remarkably plastic in culture, reflecting experimental variables 
rather than being innate (Du et al., 2015).  Given this plasticity, cell-substrate interactions have 
been studied in efforts to promote maturity, and several strategies, including changes to 
biochemical composition, stiffness and topographical micropatterning, have been used. These 
can promote the calcium cycling properties of myocytes so that they better resemble those of 
adult myocytes (Rao et al., 2013; Trantidou et al., 2014). Myocardial slices are also being used 
as even more organotypic templates (Camelliti et al., 2011). 
Reprogramming and genome editing 
Eric Olson (University of Texas Southwestern Medical Center) – the scientific father, 
grandfather, or godfather of many of the workshop participants – described high-throughput 
studies to enhance the efficiency of cardiac reprogramming. Identified in a screen of 192 human 
protein kinases, Akt markedly increases the yield of beating cardiomyocytes generated by the 
combination of Gata4, Hand2, Mef2c, and Tbx5; this was attributed to the Akt target mTOR, 
which improves bioenergetics, and to Akt down-regulating Foxo3a, a transcription factor that 
inhibits reprogramming (Zhou et al., 2015). Wider screens encompassing transcription factors, 
epigenetic regulators, nuclear receptors, and cytokines yielded 8 novel inducers as well as 
novel barriers. Olson also discussed how genome editing by CRISPR-Cas9 has been applied to 
prevent Duchenne’s muscular dystrophy in mdx mice, which have a truncated form of 
dystrophin (Long et al., 2014). Translating this to humans, Olson and colleagues devised a gene 
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editing strategy that exploited non-homologous end-joining-mediated permanent exon skipping 
and the high redundancy of dystrophin’s internal rod domains. Proof-of-concept results 
demonstrate that the defect can be corrected in human induced pluripotent stem cell-derived 
cardiomyocytes (hiPSC-CMs) from a patient with muscular dystrophy. Following this, adeno-
associated viruses were engineered for delivering Cas9 and guide RNAs, and were used to 
rescue dystrophin protein in mdx mice to functionally significant degrees (Long et al., 2016).   
Kathy Ivey (Gladstone Institute of Cardiovascular Disease, San Francicso, USA) also 
spoke on human iPSC gene editing using CRISPR-Cas9. Building on information obtained from 
model organisms on transcriptional circuits controlling cardiogenesis, Gladstone investigators 
launched the BioFulcrum initiative (https://gladstone.org/our-science/biofulcrum), aimed at 
defining transcription factor localization and network dynamics during human cardiomyocyte 
differentiation.  To achieve this, in differentiating hiPSCs, roughly 25 endogenous transcription 
factor genes are being epitope-tagged, enabling studies of factor binding throughout the 
genome (via ChIP-seq) and of protein-protein complexes (via affinity-purification mass 
spectrometry). Concomitantly, fluorescent reporter iPSC lines are being engineered, indicative 
respectively of the atrial (SLN) or ventricular (MYL3) myocyte lineage. 
The use of reprogrammed cells to model human disorders was discussed by Deepak 
Srivastava (Gladstone Institute of Cardiovascular Disease, San Francicso, USA), focusing on 
GATA4 mutations that cause congenital heart disease (Garg et al., 2003). Patients harboring a 
G296S mutation develop cardiomyopathy as teenagers despite repair of the septal and valve 
defects in childhood. Using hiPSC-CMs derived from these patients, the Srivastava lab is using 
bioengineering approaches to study how this mutation affects myocyte alignment, 
electrophysiology and mechanical performance. Further studies, using ChIP-Seq for GATA4 and 
TBX5, are providing insights into how the GATA4 mutation disrupts interactions with TBX5 at 
“super-enhancers” and modulates the cardiogenic gene programme.  Srivastava also discussed 
his group’s efforts to enhance direct programming to cardiomyocytes using small molecule 
screening, carried out in collaboration with Gladstone investigator Sheng Ding (Wang et al., 
2014; Zhu et al., 2015). Using a transcription factor cocktail comprising Gata4, Mef2c, and Tbx5 
as starting point, the group identified molecules that could improve quality and accelerate the 
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reprogramming process in vitro and in vivo. Building on this, an all-chemical cocktail of nine 
compounds has been successfully devised for the cardiogenic conversion of human fibroblasts. 
Obstacles to direct cardiac reprogramming were discussed by Li Qian (University of 
North Carolina, Chapel Hill, USA).  To address relative dosing and overcome the heterogeneity 
of viral transduction when factors are delivered singly, an optimised polycistronic vector was 
developed for Mef2c, Gata4 and Tbx5 (Ma et al., 2015; Wang et al., 2015a; Wang et al., 2015b). 
Qian also investigated epigenetic impediments and, using a loss-of-function screen, showed 
that loss of the Polycomb Repressive Complex 1 component Bmi1 enhances cardiac 
programming 3-fold, which was generalizable to various reported gene cocktails and recipient 
somatic cell types. Augmentation did not involve Bmi1 target genes with known roles in cell 
proliferation (p16INK4a, p19ARF, p53), but rather an unrecognized function of the protein that 
involves direct binding to the promoters of cardiogenic genes (Gata4, Nkx2-5, Isl1, Pitx2, Tbx20) 
and the exchange of repressive histone marks for active ones. Accordingly, Bmi1-depleted cells 
could be reprogrammed successfully using just Mef2c and Tbx5. 
Alessandra Moretti (Technical University Munich, Germany) used an iPSC-based 
approach to investigate the pathology of the hereditary heart muscle disorder, arrhythmogenic 
right ventricular dysplasia (ARVC). Cardiomyocytes generated from iPSCs derived from ARVC 
patients spontaneously acquire brown-beige fat characteristics and progressively up-regulate 
adipocytic genes whilst exhibiting disruption of sarcomere organization and loss of myocytic 
identity. The ability of cardiomyocytes to spontaneously adopt a beige adipocyte phenotype in 
disease suggests a possible developmental relationship between these two cell lineages. Using 
genetic fate-mapping in the mouse and the clonal differentiation of ESC-derived cardiovascular 
precursors, Moretti identified a subset of primordial Isl1+/Wt1+ progenitors that are bipotent and 
give rise to both cardiomyocyte and adipocyte lineages. These findings illustrate a naturally 
occurring conversion of heart muscle into beige fat in human disease and provide a foundation 
to prevent or revert the process as a potential therapeutic strategy.  
Together, these reprograming and genome editing approaches demonstrate the ever-
increasing sophistication of methods to impose a cardiomyocyte phenotype in non-muscle cells, 
the utility of patient-specific stem cell-derived cardiomyocytes as a springboard to translation, 
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and the dawn of CRISPR-Cas9 methods for targeted mutagenesis or gene correction.  
Transcription factor networks 
Benoit Bruneau (Gladstone Institute of Cardiovascular Disease, San Francisco, USA) 
provided a perspective on gene regulatory networks and chromatin remodeling, focusing on 
Tbx5 and Nkx2-5. Tbx5, Nkx2-5, and Gata4 binding sites were analysed by ChIP-exo for ultra-
high resolution mapping (Rhee and Pugh, 2011; Luna-Zurita et al., 2016). Sites of triple, double, 
or single occupancy were identified, the triple sites correlating with active chromatin and 
differential expression. Factor knockouts result in ectopic binding, e.g. Tbx5 to Pecam in the 
absence of Nkx2-5, and Nkx2-5 to Corin in the absence of Tbx5, concordant with up-regulation 
of endocardial and neural genes. The factors together possess ten-fold higher binding affinity 
than either alone, and by crystallography the ternary complex encompassing both was seen to 
induce DNA bending. Thus heterotypic factor interactions contribute not only to decreased 
binding but also to ectopic binding. 
The binding of Nkx2-5 binding to embryonic cardiac enhancers was also investigated by 
Laurent Dupays (Crick Institute, London, UK). ChIP on E11.5 mouse heart identified more than 
2500 Nkx2-5 binding sites (Blow et al., 2010; Dupays et al., 2015). Two binding motifs were 
identified, one of which was reminiscent of the binding motif for Meis1, a cardiac cell cycle 
regulator (Stankunas et al., 2008; Mahmoud et al., 2013). Meis and Nkx2-5 are expressed 
successively in cardiac progenitors and bind sequentially to this motif.  At E9.5, Meis1 
enrichment predominates in the AHF, while Nkx2-5 predominates in the heart, resembling the 
factors’ respective levels of expression. The “hits” for Nkx2-5 alone were principally cardiac, 
whereas dually bound sites associated at least equally with diverse other functions. Notably, 
only half the target genes bound by Nkx2-5 are down-regulated in mice defective for Nkx2-5; the 
other half are up-regulated, indicating that repression is an important direct role of this factor. 
Brian L Black (University of California, San Francisco, USA) discussed transcriptional 
regulation of Prkaa2, which encodes the alpha2 subunit of AMP-activated protein kinase 
(AMPK), a key therapeutic target in metabolic syndrome, type 2 diabetes and cardioprotection 
(Qi and Young, 2015).   Epigenetic datasets were mined for evolutionary conservation of non-
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coding sequences within 100 kb of the Prkaa2 start site, and a predicted cardiac enhancer was 
identified.  A 1-kb piece identified in these screens was tested in vivo in transgenic mouse 
embryos and was found to direct lacZ expression exclusively to the heart throughout 
embryogenesis and in the adult. Conversely, CRISPR-mediated deletion of the region 
substantially reduced endogenous Prkaa2 expression, establishing that this element serves as 
a bona fide enhancer. Deletion analyses in lacZ transgenic mice revealed a necessary and 
sufficient segment for enhancer activity in vivo.  The transcriptional regulation of the enhancer 
by an upstream transcriptional network was discussed, and a cooperative mechanism for this 
enhancer and for cardiac enhancers in general was proposed. 
Transcriptomic, proteomic and genomic studies 
Several presentations analysed the more global changes occurring during heart 
regeneration. For example, building on the regenerative capacity of the neonatal mouse 
(Porrello et al., 2011; Porrello et al., 2013), Enzo Porrello (University of Queensland, Brisbane, 
Australia) described transcriptomic profiling of adult versus neonatal infarction, surveying 
diverse participating cells including cardiomyocytes, endothelial cells, fibroblasts  and 
leukocytes. By principal component analysis, Porrello showed that leukocytes and fibroblasts 
revert to a neonatal state after infarction; myocytes and endothelial cells, in contrast, fail to 
revert to a neonatal state, even though myocytes account for many differentially expressed 
genes. To revert an adult myocyte to a neonatal state thus may require overcoming epigenetic 
barriers that are laid down in postnatal development. Although in vitro models of engineered 
human heart tissue would be attractive to study this problem, most suffer from immaturity, 
laboriousness, and lack of amenability to high-throughput screening. For these reasons, 96-well 
plates with flexible micropillars in each well — enabling a more native architecture and semi-
automated analysis of force production – have been devised and applied successfully to screen 
for combinatorial conditions that promote cardiomyocyte maturation.  
Studies mapping the transcriptome of the injured mouse heart were presented by Rob 
Janssen (Academic Medical Center, Amsterdam, Netherlands), who suggested that 
regeneration is initiated but not completed by adult cardiomyocytes in the infarct border zone. 
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Nppa and Nppb are highly expressed in the border zone in mice and fish, with antibodies to p-
Smad1/5/8 suggesting the BMP pathway is activated there. Spatially resolved expression 
profiles after coronary artery ligation are currently being analysed by genome-wide RNA 
tomography (Tomo-Seq) (Junker et al., 2014), as implemented for the regenerating zebrafish 
heart (Wu et al., 2016), while an Nppb-driven far-red fluorescent protein, Katushka, is being 
used to label the border zone following infarction (Sergeeva et al., 2014) and will enable the 
comparison of positive and negative myocytes.   
Antonio Beltrami (University of Udine, Italy) examined the gene expression profiles of 
cardiac-derived multipotent stem cells, which have unique features, including a mesothelial 
signature (Verardo et al., 2014), and coexpress mesenchymal and pericytic markers together 
with c-kit (Avolio et al., 2015). In immunodeficient mice subjected to infarction, human cardiac 
stem cells and a pericyte/mesenchymal population from human saphenous veins (Campagnolo 
et al., 2010) were superior to each other respectively in promoting myocyte proliferation and c-
kit+ stem cell recruitment versus promoting angiogenesis, suggesting a rationale for combination 
therapy (Avolio et al., 2015).  
Finally, Nadia Rosenthal (The Jackson Laboratory, Bar Harbor, USA) investigated subtle 
complexities in immune cells and fibroblasts during tissue repair. Characteristically, wound 
healing entails infiltration by neutrophils, then macrophages, then T cells and mast cells, with 
macrophages shifting from a pro-inflammatory (M1) to anti-inflammatory (M2) state.  Insulin-like 
growth factor-1 (IGF-1) has been implicated in multiple macrophage responses, and Rosenthal 
showed that its deletion just in the macrophage compartment abrogates M2 polarization and 
muscle regrowth in mice. Conversely, over-expressing IGF-1 in skeletal muscle accelerates the 
M2 phase and regeneration (Tonkin et al., 2015), as does transgenic over-expression in the 
heart or clinically relevant delivery to adult myocardium with AAV9 (Gallego-Colon et al., 2015; 
Gallego-Colon et al., 2016). Fibroblast action is also important in determining infarct outcome: 
cardiac fibroblasts express an unexpected cardiogenic gene program, and infarct repair is 
improved by ablating Tbx20 in the fibroblast compartment (Furtado et al., 2014; Furtado et al., 
2016). Cardiac fibroblast number is also markedly reduced in IGF-1-over-expressing transgenic 
mice, and in more effectively regenerating strains, as revealed by comparing roughly 30 strains 
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from the Collaborative Cross recombinant inbred mouse panel (Churchill et al., 2004; Threadgill 
and Churchill, 2012); this approach has already defined several infarct-related quantitative trait 
loci.      
Perspectives 
A closing summary by Jim Martin highlighted the meeting’s principal recurring and 
emerging themes and was followed by an engaging discussion of why the human heart appears 
to be so limited in its regenerative capacity.  Participants agreed that restarting cardiomyocyte 
proliferation, either via Hippo, Neuregulin or newly discovered pathways, is incontrovertibly 
feasible, but how might one best exploit those targets for investigation and therapy? Studies of 
zebrafish heart repair now prompt the mining of regeneration-specific enhancers, genetic 
programmes, and cellular factors that promote myocyte expansion. The identity and function 
other cell types that contribute to heart repair remain puzzling but are beginning to be unraveled 
via single-cell analyses, imaging and transcriptomics. Still other secrets of restorative growth 
have succumbed to innovations in advanced mouse genetics and genome editing, while input 
from the field of material science and bioengineering has provided the means to enhance 
reprogramming, durable engraftment and myocyte maturity. The prospects for translation to 
human hearts are so imminent, that several leading zebrafish and mouse labs have already 
embarked on large-mammal studies, building solidly on the discoveries made in accessible, 
genetically tractable reductionist model systems. 
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